DKN-01 Monotherapy Demonstrated Clinical Activity in Patients with Endometrial Cancer
- Tumoral DKK1 Expression Biomarker Predicts Strongest Outcomes
- Conference Call to Discuss Results Today at 8:30 a.m. Eastern Time
Leap will be hosting a conference call today at 8:30 a.m. Eastern Time with Dr. Arend and members of Leap's management team to discuss the data. The call can be accessed by dialing (866) 589-0108 (U.S. and Canada) or (409) 231-2048 (international). The passcode for the conference call is 2077923. The presentation will be webcast live and may be accessed on the Investors page of the company's website at https://investors.leaptx.com/, where a replay of the event will also be available for a limited time.
https://finance.yahoo.com/news/leap-therapeutics-presents-dkn-01-100000184.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.